AIM bulletins from ShareCast
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Revenue falls short but profitability improves for Velocity Composites
Wed 05 November 2025 17:10
(Sharecast News) - Velocity Composites said in an update on Wednesday that annual revenue fell short of expectations due to delays in key aerospace programmes, although profitability improved as operational efficiencies boosted margins and cut costs.
Oriole inks completion agreement with BCM International
Wed 05 November 2025 17:01
(Sharecast News) - Oriole Resources announced a completion agreement with BCM International on Wednesday, covering its earn-in arrangements on the Bibemi and Mbe gold projects in Cameroon, securing funding for a new drilling programme at Mbe-North and fur
Alien Metals reports new silver intersection at Elizabeth Hill
Wed 05 November 2025 14:42
(Sharecast News) - Alien Metals said in an update on Wednesday that native silver had been intersected in new drilling at the Elizabeth Hill project in Western Australia, confirming near-surface mineralisation at one of the country's highest-grade histori
TPXimpact on track to meet full-year guidance
Wed 05 November 2025 14:39
(Sharecast News) - TPXimpact said in an update on Wednesday that it was on track to meet full-year guidance after an encouraging first half, as improved profitability and tighter financial management reduced net debt and supported stronger cash generation
Kitwave trading in line with expectations, CFO to step down
Wed 05 November 2025 14:36
(Sharecast News) - Kitwave Group said in an update on Wednesday that it expects full-year profit to be in line with market expectations after trading in the second half of its financial year met forecasts, as it also announced the upcoming retirement of i
Hutchmed enrols last patient in phase three lung cancer trial
Wed 05 November 2025 14:22
(Sharecast News) - Hutchmed China said in an update on Wednesday that it has completed patient enrollment for its global phase three 'Saffron' trial evaluating the combination of Orpathys and Tagrisso in certain lung cancer patients with MET overexpressio
Vianet reports solid first-half results
Tue 04 November 2025 16:27
(Sharecast News) - Vianet Group reported solid first-half results for the six months ended 30 September on Tuesday, underpinned by strong recurring income, improved margins and disciplined cost control, as the group proposed a 33% increase in its interim